20 - CRISPR-Cas9 Optogenetic System for Insulin Expression in Human Embryonic Stem Cell-Derived β-Like Cells
Publication date: October 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 7, SupplementAuthor(s): Evgeniy Panzhinskiy, Helen Huang, Kate Macdonald, James Johnson, Francis C. Lynn
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Canada Health | Diabetes | Endocrinology | Insulin | Opthalmology | Stem Cell Therapy | Stem Cells